Discover undervalued stocks with Eulerpool.

Subscribe for $2

Semler Scientific Stock SMLR

Price

0
Today +/-
-0
Today %
-0 %

Semler Scientific stock price

Loading chart...
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Semler Scientific stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Semler Scientific stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Semler Scientific stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Semler Scientific's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Semler Scientific Stock Price History

DateSemler Scientific Price
10/18/20250 undefined
10/17/202523.05 undefined
10/17/202524.28 undefined
10/16/202524.86 undefined
10/15/202525.61 undefined
10/14/202525.69 undefined
10/13/202526.31 undefined
10/10/202526.38 undefined
10/10/202526.21 undefined
10/9/202528.30 undefined
10/8/202528.41 undefined
10/7/202528.59 undefined
10/6/202530.82 undefined
10/3/202530.66 undefined
10/3/202530.08 undefined
10/2/202531.25 undefined
10/1/202531.31 undefined
9/29/202530.00 undefined
9/28/202529.24 undefined
9/25/202528.31 undefined
9/24/202530.21 undefined
9/24/202531.62 undefined
9/24/202532.11 undefined
9/23/202532.51 undefined
9/22/202531.71 undefined
9/19/202529.01 undefined
9/19/202529.16 undefined

Semler Scientific Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Semler Scientific, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Semler Scientific from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Semler Scientific’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Semler Scientific. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Semler Scientific’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Semler Scientific’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Semler Scientific’s growth potential.

Semler Scientific Revenue, EBIT and net profit per share

DateSemler Scientific RevenueSemler Scientific EBITSemler Scientific Net Income
2027e33.45 M undefined-27.4 M undefined-12.35 M undefined
2026e27.64 M undefined-9.19 M undefined-3.47 M undefined
2025e32.19 M undefined-37.12 M undefined-19.61 M undefined
202456.29 M undefined20.93 M undefined40.9 M undefined
202368.18 M undefined22.26 M undefined20.58 M undefined
202256.69 M undefined17.2 M undefined14.33 M undefined
202153.03 M undefined19.45 M undefined17.22 M undefined
202038.6 M undefined15.96 M undefined14.01 M undefined
201932.77 M undefined10.71 M undefined15.08 M undefined
201821.49 M undefined5.34 M undefined5.01 M undefined
201712.45 M undefined-850,000 undefined-1.51 M undefined
20167.43 M undefined-2.16 M undefined-2.55 M undefined
20157 M undefined-8.42 M undefined-8.5 M undefined
20143.64 M undefined-4.34 M undefined-4.52 M undefined
20132.27 M undefined-2.12 M undefined-2.23 M undefined
20121.2 M undefined-2.42 M undefined-2.83 M undefined
2011320,000 undefined-1.78 M undefined-1.88 M undefined

Semler Scientific Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)
REVENUE GROWTH (%)
GROSS MARGIN (%)
GROSS INCOME (M)
NET INCOME (M)
NET INCOME GROWTH (%)
SHARES (M)
DOCUMENTS
201120122013201420152016201720182019202020212022202320242025e2026e2027e
0123771221323853566856322733
--100.0050.00133.33-71.4375.0052.3818.7539.475.6621.43-17.65-42.86-15.6322.22
-5,100.0050.0066.6757.1471.4375.0085.7190.6392.1186.7992.8689.7191.07159.38188.89154.55
001245918293546526151000
-1-2-2-4-8-2-15151417142040-19-3-12
-100.00-100.00100.00-75.00-50.00-600.00200.00-6.6721.43-17.6542.86100.00-147.50-84.21300.00
4.64.64.64.114.935.125.417.638.038.078.1487.827.98000
- - - - - - - - - - - - - - - - -
Details

Keystats

ⓘ

Revenue and Growth

The Semler Scientific Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Semler Scientific is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETS
CASH BALANCE (M)
RECEIVABLES (M)
OTHER REC. (M)
INVENTORIES (k)
OTHER CURRENT LIAB. (M)
CURRENT ASSETS (M)
TANGIBLE ASSETS (M)
LONG-T. INVEST. (M)
LONG-T. REC. (M)
INTANGIBLE ASSETS (M)
GOODWILL (M)
OTHER NON-CURRENT ASSETS (M)
NON-CURRENT ASSETS (M)
TOTAL ASSETS (M)
LIABILITIES
COMMON STOCK (M)
ADDITIONAL PAID-IN CAPITAL (M)
RETAINED EARNINGS (M)
OTHER EQUITY (M)
UNREAL. GAINS/LOSSES (M)
EQUITY (M)
LIABILITIES (k)
PROVISIONS (M)
OTHER SHORT-TERM LIAB. (M)
SHORT-TERM DEBTS (M)
LONG-TERM DEBT PORTION (M)
SHORT-TERM REC. (M)
LONG-T. LIAB. (M)
DEFERRED TAXES (M)
OTHER LIAB. (k)
LONG-T. LIABILITIES (M)
DEBT (M)
TOTAL CAPITAL (M)
20112012201320142015201620172018201920202021202220232024
                           
0.030.730.734.160.410.621.463.287.7422.0837.3243.0957.214.92
0.020.080.230.361.280.881.322.83.492.813.623.886.134.38
00000000000000
000000000340550470445358
0.010.020.052.240.070.090.110.150.221.384.041.472.173.03
0.060.831.016.761.761.592.896.2311.4526.6145.5348.9165.9422.69
0.240.360.510.681.331.471.341.472.332.22.353.383.161.98
0000000003.050.825.55.880.51
00000000000000
0000000000000214.63
00000000000000
0.380.290.20.0700.020.020.024.522.781.964.913.080.02
0.620.650.710.751.331.491.361.496.858.035.1313.7912.12217.14
0.681.481.727.513.093.084.257.7218.334.6450.6662.778.07239.83
                           
04.296.710.010.010.010.010.010.010.010.010.010.010.01
3.912.852.3517.321.292223.8425.6119.422.1120.6516.4511.99130.04
-4.38-7.12-9.35-13.87-22.37-24.92-26.43-21.42-6.337.6724.939.2259.8100.7
00000000029.790000
00000000000000
-0.470.02-0.293.44-1.07-2.91-2.584.213.0859.5845.5655.6871.8230.75
1209026090840450490280340680440840402140
0.40.91.131.362.322.192.872.83.912.873.524.834.595.24
0.150.10.370.610.950.510.530.440.960.960.921.191.210.93
00000000000000
0.10.10.11200.081.260000000
0.771.191.874.064.113.235.153.525.214.514.886.866.26.31
0.370.270.16002.531.670000000
00000000000002.77
000040230101010330250160700
0.370.270.1600.042.761.680.010.010.330.250.160.072.77
1.141.462.034.064.155.996.833.535.224.845.137.026.279.08
0.671.481.747.53.083.084.257.7318.364.4250.6962.778.07239.83
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Semler Scientific provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Semler Scientific's financial health and stability.

Assets

Semler Scientific's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Semler Scientific must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Semler Scientific after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Semler Scientific's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)
DEPRECIATION (M)
DEFERRED TAXES (M)
CHANGES IN WORKING CAPITAL (k)
NON-CASH ITEM (M)
PAID INTEREST (M)
PAID TAXES (M)
NET CASH FLOW FROM OPERATING ACTIVITIES (M)
CAPITAL EXPENDITURES (M)
CASH FLOW FROM INVESTING ACTIVITIES (M)
CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)
INTEREST INCOME AND EXPENSES (M)
NET DEBT CHANGE (M)
NET CHANGE IN EQUITY (M)
CASH FLOW FROM FINANCING ACTIVITIES (M)
CASH FLOW FROM OTHER FINANCING ACTIVITIES ()
TOTAL DIVIDENDS PAID (M)
NET CHANGE IN CASH FLOW (M)
FREE CASH FLOW (M)
SHARE-BASED COMPENSATION (M)
2011201220132014201520162017201820192020202120222023
-1-2-2-4-8-2-151514171420
0000000000000
00000000-42000
0000000-1,0000-1,000-4,0001,000-3,000
0000511100315
0000000000000
0000000000224
-1-1-1-3-4-1041215161721
0000-1000-100-20
000-21000-1-10-2618
000-22000000-2419
0000000000000
0001-220-200000
032101010-600-4-1
1219021-2-600-4-5
----1.00---------3.00
0000000000000
0003-300141415-1434
-1.47-2.01-1.63-4.26-5.24-2.61-0.353.8611.0314.3515.2315.320.5
0000000000000

Semler Scientific stock margins

The Semler Scientific margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Semler Scientific. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Semler Scientific.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Semler Scientific's sales revenue. A higher gross margin percentage indicates that the Semler Scientific retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Semler Scientific's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Semler Scientific's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Semler Scientific's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Semler Scientific. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Semler Scientific's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Semler Scientific Margin History

Semler Scientific Gross marginSemler Scientific Profit marginSemler Scientific EBIT marginSemler Scientific Profit margin
2027e91.55 %-81.91 %-36.93 %
2026e91.55 %-33.25 %-12.57 %
2025e91.55 %-115.33 %-60.93 %
202491.55 %37.19 %72.65 %
202389.76 %32.64 %30.19 %
202292.49 %30.34 %25.28 %
202188.46 %36.68 %32.47 %
202091.32 %41.35 %36.3 %
201988.83 %32.68 %46.02 %
201887.44 %24.85 %23.31 %
201779.52 %-6.83 %-12.13 %
201674.83 %-29.07 %-34.32 %
201559.29 %-120.29 %-121.43 %
201480.77 %-119.23 %-124.18 %
201379.74 %-93.39 %-98.24 %
201270 %-201.67 %-235.83 %
201153.13 %-556.25 %-587.5 %

Semler Scientific Stock Sales Revenue, EBIT, Earnings per Share

The Semler Scientific earnings per share therefore indicates how much revenue Semler Scientific has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Semler Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Semler Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Semler Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Semler Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Semler Scientific Revenue, EBIT and net profit per share

DateSemler Scientific Sales per ShareSemler Scientific EBIT per shareSemler Scientific Earnings per Share
2027e2.21 undefined-3.43 undefined-0.82 undefined
2026e1.83 undefined-1.15 undefined-0.23 undefined
2025e2.13 undefined-4.65 undefined-1.3 undefined
20247.05 undefined2.62 undefined5.13 undefined
20238.72 undefined2.85 undefined2.63 undefined
20227.09 undefined2.15 undefined1.79 undefined
20216.51 undefined2.39 undefined2.12 undefined
20204.78 undefined1.98 undefined1.74 undefined
20194.08 undefined1.33 undefined1.88 undefined
20182.82 undefined0.7 undefined0.66 undefined
20172.3 undefined-0.16 undefined-0.28 undefined
20161.45 undefined-0.42 undefined-0.5 undefined
20151.42 undefined-1.71 undefined-1.72 undefined
20140.89 undefined-1.06 undefined-1.1 undefined
20130.49 undefined-0.46 undefined-0.48 undefined
20120.26 undefined-0.53 undefined-0.62 undefined
20110.07 undefined-0.39 undefined-0.41 undefined

Semler Scientific business model

Semler Scientific Inc. is a company that develops and manufactures medical devices aimed at improving people's health while reducing costs for the healthcare system. The company was founded in California in 2007 and has since become a leading provider of medical diagnostic and screening tools. Semler Scientific's business model is based on the development and marketing of medical devices that enable doctors and medical personnel to detect medical conditions early on without the need for expensive and invasive examinations. The company is divided into several divisions, including cardiology, neurology, general medicine, and internal medicine. By developing specialized products for each of these divisions, Semler Scientific helps improve diagnosis and screening efficiency while reducing healthcare costs. One of Semler Scientific's main products is QuantaFlo®, a device that helps doctors and medical personnel detect circulation disorders in the legs. This is an important step in diagnosing conditions such as diabetes, heart disease, and other conditions that can affect blood flow. QuantaFlo® is a simple, non-invasive device that can be quickly and easily used. Another important product from Semler Scientific is WellChec®, a screening tool that helps doctors and medical personnel detect and treat possible signs of chronic conditions such as diabetes, heart disease, and cancer. WellChec® is based on a comprehensive check-up system that can be easily and efficiently performed by doctors and medical personnel. The system includes a variety of tests and examinations, including ultrasound and EKG tests, as well as blood and urine tests, to provide patients with comprehensive medical diagnosis and treatment. Semler Scientific has experienced impressive growth in recent years, not only developing new products but also expanding into new markets. The company recently opened a branch in Europe to serve the growing European market. Semler Scientific's business model has proven to be successful and has shown that there is a high demand for effective, efficient, and cost-effective medical devices in today's healthcare landscape. The company is constantly striving to develop new and innovative products to further improve the diagnosis and screening process and enhance the health of people worldwide. With a dedicated team of medical experts, technologists, and engineers, Semler Scientific aims to continue leading in the field of medical diagnostics and screening technologies. Semler Scientific is one of the most popular companies on Eulerpool.com.

Semler Scientific SWOT Analysis

Strengths

Semler Scientific Inc. has developed cutting-edge healthcare technology, offering innovative solutions and diagnostic devices that help medical professionals accurately assess patient health and improve healthcare outcomes.

The company has established a strong presence in the healthcare market, with an extensive network of clients including hospitals, clinics, and healthcare providers worldwide. This wide market reach provides Semler Scientific with significant opportunities for growth and expansion.

Semler Scientific Inc. emphasizes research and development, continually striving to enhance existing technologies and develop new products. This commitment to innovation enables the company to stay ahead of market trends, adapt to changing customer needs, and maintain a competitive edge.

Weaknesses

As a healthcare technology company, Semler Scientific is highly dependent on the overall success and growth of the healthcare industry. Any disruptions or downturns in the industry could have a significant impact on the company's financial performance and market position.

While Semler Scientific offers state-of-the-art diagnostic devices, its product portfolio is relatively limited compared to some competitors. This narrow range of offerings could limit the company's ability to fully capture opportunities in various healthcare segments and potentially result in missed revenue potential.

Opportunities

The increasing global healthcare expenditure presents a significant opportunity for Semler Scientific Inc. to expand its market share and revenue. As healthcare spending continues to rise, there is a growing demand for advanced diagnostic technologies, which the company is well-positioned to fulfill.

Expanding into emerging markets offers Semler Scientific the chance to tap into new customer bases and geographical regions. These markets often present untapped potential and can contribute to the company's revenue growth in the long term.

Threats

The healthcare technology industry is highly competitive, with numerous companies vying for market share. Semler Scientific faces the risk of losing customers to competitors offering similar or more advanced products. To mitigate this threat, the company needs to continuously invest in research and development to maintain its technological edge.

The healthcare industry is subject to stringent regulations and compliance requirements, which can pose challenges for Semler Scientific's product development and commercialization efforts. Adhering to these regulations may increase costs and lengthen the time it takes to bring new products to market.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Semler Scientific Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Semler Scientific historical P/E ratio, EBIT multiple, and P/S ratio

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2

Semler Scientific shares outstanding

The number of shares was Semler Scientific in 2024 — This indicates how many shares 7.98 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Semler Scientific earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Semler Scientific's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Semler Scientific’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Semler Scientific's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Eulerpool Premium

The World’s Best Investors Are On Eulerpool

Subscribe for $2
Unfortunately, there are currently no price targets and forecasts available for Semler Scientific.

Semler Scientific latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
6/30/2025-0.28 5.04  (1,930.07 %)2025 Q2
3/31/20250 -0.76  (0 %)2025 Q1
12/31/20240.2 3.41  (1,571.57 %)2024 Q4
9/30/20240.38 0.72  (90.78 %)2024 Q3
6/30/20240.57 0.64  (12.04 %)2024 Q2
3/31/20241.05 0.78  (-25.76 %)2024 Q1
12/31/20230.58 0.59  (1.48 %)2023 Q4
9/30/20230.52 0.78  (49.94 %)2023 Q3
6/30/20230.57 0.75  (31.3 %)2023 Q2
3/31/20230.59 0.63  (6.49 %)2023 Q1
1
2
3
4

Eulerpool ESG Scorecard© for the Semler Scientific stock

Eulerpool World ESG Rating (EESG©)

15/ 100

🌱 Environment

14

👫 Social

14

🏛️ Governance

16

Environment

Scope 1 - Direct Emissions
Scope 2 - Indirect emissions from purchased energy
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Semler Scientific shareholders

%
Name
Stocks
Change
Date
8.48464 % Interchange Capital Partners LLC1,284,57506/30/2025
6.18801 % Ridgeback Capital Management, L.P.936,865936,8657/11/2025
5.84994 % Chang Family Trust885,6811,4176/30/2025
5.17401 % Morgan Stanley Investment Management Inc. (US)783,345310,2416/30/2025
4.71610 % Semler (Eric J.D.)714,0176,6506/30/2025
4.60342 % Capital Research Global Investors696,95877,1796/30/2025
4.60342 % Capital International Investors696,95877,1796/30/2025
4.22370 % The Vanguard Group, Inc.639,468198,7626/30/2025
4.07726 % Citadel Advisors LLC617,297602,4186/30/2025
3.84384 % BlackRock Institutional Trust Company, N.A.581,957115,1486/30/2025
1
2
3
4
5
...
10

Semler Scientific Executives and Management Board

Dr. Douglas Murphy-chutorian

(71)
Semler Scientific Chief Executive Officer, Director (since 2012)
Compensation 1.11 M

Ms. Renae Cormier

(53)
Semler Scientific Chief Financial Officer
Compensation 730,949

Mr. Eric Semler

(60)
Semler Scientific Executive Chairman (since 2023)
Compensation 488,200

Mr. William Chang

(68)
Semler Scientific Independent Director
Compensation 453,700

Mr. Daniel Messina

(69)
Semler Scientific Independent Director
Compensation 170,500
1
2

Semler Scientific Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Becton, Dickinson Stock
Becton, Dickinson
SupplierCustomer0,31-0,350,61-0,15-0,60-0,24
1

Most common questions regarding Semler Scientific

What values and corporate philosophy does Semler Scientific represent?

Semler Scientific Inc represents values of innovation, integrity, and excellence. With a corporate philosophy focused on improving healthcare outcomes, Semler Scientific Inc strives to provide cutting-edge medical solutions. The company is dedicated to developing and commercializing proprietary technology and products that enhance the early detection and management of chronic diseases. By utilizing advanced algorithms and data analytics, Semler Scientific Inc empowers healthcare professionals to make informed decisions and deliver personalized care. With a commitment to improving patient outcomes and reducing healthcare costs, Semler Scientific Inc continues to make significant strides in the field of medical diagnostics.

In which countries and regions is Semler Scientific primarily present?

Semler Scientific Inc primarily operates and serves customers in the United States.

What significant milestones has the company Semler Scientific achieved?

Semler Scientific Inc has achieved significant milestones over the years. One notable accomplishment is the development and commercialization of their flagship product, QuantaFlo™. This revolutionary device has revolutionized the field of vascular testing by providing a non-invasive and accurate method for detecting peripheral artery disease. Additionally, the company has successfully expanded its customer base, partnering with prominent healthcare organizations worldwide. Semler Scientific Inc has also been recognized for its continuous efforts in research and innovation, receiving multiple awards for its breakthrough medical technologies. Such accomplishments highlight the company's commitment to improving patient outcomes and solidify its position as a leader in the healthcare industry.

What is the history and background of the company Semler Scientific?

Semler Scientific Inc is a company that specializes in developing and marketing medical devices to aid healthcare providers in the early detection and prevention of diseases. Founded in 2007, Semler Scientific Inc has made significant strides in the healthcare industry, particularly in the field of cardiovascular disease management. They have achieved notable success with their innovative products, including their FDA-approved device, the QuantaFlo™ System, which utilizes advanced technology to assess blood flow and identify potential cardiovascular issues. Semler Scientific Inc has built a solid reputation for providing reliable and effective solutions that contribute to better patient outcomes and improved healthcare practices.

Who are the main competitors of Semler Scientific in the market?

The main competitors of Semler Scientific Inc in the market include a range of healthcare companies such as Hill-Rom Holdings, Inc., Danaher Corporation, and Masimo Corporation. These companies operate in the medical technology and diagnostics industry, offering similar products and services to healthcare providers. Semler Scientific Inc competes with these companies by providing innovative solutions and advanced technologies that enhance patient care and improve healthcare outcomes.

In which industries is Semler Scientific primarily active?

Semler Scientific Inc is primarily active in the healthcare industry, specifically focused on providing solutions for early detection and prevention of chronic diseases.

What is the business model of Semler Scientific?

The business model of Semler Scientific Inc revolves around providing healthcare solutions through its proprietary technology and products. Semler Scientific focuses on developing and commercializing innovative medical devices for screening and detection of chronic diseases. By leveraging advanced algorithms and data analytics, the company's devices enable early diagnosis and prevention, enhancing patient outcomes and reducing healthcare costs. Semler Scientific aims to create value by partnering with healthcare providers and payors to improve patient care and drive efficiency in the healthcare system. With its strong focus on innovation and improving healthcare outcomes, Semler Scientific Inc continues to play a vital role in the medical industry.

What is the P/E ratio of Semler Scientific 2025?

The P/E ratio cannot be calculated for Semler Scientific at the moment.

What is the P/S ratio of Semler Scientific 2025?

The P/S cannot be calculated for Semler Scientific currently.

What is the Quality Investing of Semler Scientific?

The Quality Investing for Semler Scientific is 3/10.

What is the revenue of Semler Scientific 2025?

The expected Semler Scientific revenue is 32.19 M USD.

How high is the profit of Semler Scientific 2025?

The expected Semler Scientific profit is -19.61 M USD.

What is the business model of Semler Scientific

Semler Scientific Inc is a US-based company that specializes in the manufacture and distribution of medical diagnostic devices to identify various types of diseases. The business model of Semler Scientific Inc is focused on a simpler, more reliable, and cost-effective method of healthcare. The main product of Semler Scientific Inc is based on the technology of Disease Management Services. The company is introducing the technology across the United States to improve healthcare outcomes in care facilities and healthcare organizations. The technology is simple and precise, providing customers with a real-time option for monitoring and assessing diseases. Semler Scientific Inc's industry-leading technology, Semler HealthPerx, is based on a proprietary, algorithm-based software platform that allows healthcare providers to continuously monitor and evaluate a wide range of diseases. The product can help detect and reduce harmful health conditions such as stroke, heart disease, and kidney disease in the population of care facilities. Semler Scientific Inc has a sophisticated distribution network in the US that focuses on two main areas: the sale of basic kits and service agreements. Semler Scientific Inc's basic kits include all the necessary hardware and software components to utilize the services offered by the company. Semler Scientific Inc's service agreements include maintenance and repair services to ensure the functionality and reliability of the products. Semler Scientific Inc has a strong commitment to research and development (R&D) as part of its mission to deliver innovative technologies and services tailored to the needs of the healthcare industry. The company regularly invests in R&D to improve its products and services and collaborates closely with leading research institutions to integrate the latest developments in technology and healthcare management services. Semler Scientific Inc aims to provide its customers with the best products and services in the healthcare industry. Through continuous innovation and the highest standards in service, the company is taking diagnostic technology to the next level, improving the health and well-being of numerous patients in the US and beyond.

What is the Semler Scientific dividend?

Semler Scientific pays a dividend of 0 USD distributed over payouts per year.

How often does Semler Scientific pay dividends?

The dividend cannot currently be calculated for Semler Scientific or the company does not pay out a dividend.

What is the Semler Scientific ISIN?

The ISIN of Semler Scientific is US81684M1045.

What is the Semler Scientific WKN?

The WKN of Semler Scientific is A1XEZJ.

What is the Semler Scientific ticker?

The ticker of Semler Scientific is SMLR.

How much dividend does Semler Scientific pay?

Over the past 12 months, Semler Scientific paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Semler Scientific is expected to pay a dividend of 0 USD.

What is the dividend yield of Semler Scientific?

The current dividend yield of Semler Scientific is .

When does Semler Scientific pay dividends?

Semler Scientific pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Semler Scientific?

Semler Scientific paid dividends every year for the past 0 years.

What is the dividend of Semler Scientific?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Semler Scientific located?

Semler Scientific is assigned to the 'Health' sector.

Wann musste ich die Aktien von Semler Scientific kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Semler Scientific from 10/19/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/19/2025.

When did Semler Scientific pay the last dividend?

The last dividend was paid out on 10/19/2025.

What was the dividend of Semler Scientific in the year 2024?

In the year 2024, Semler Scientific distributed 0 USD as dividends.

In which currency does Semler Scientific pay out the dividend?

The dividends of Semler Scientific are distributed in USD.

All fundamentals about Semler Scientific

Our stock analysis for Semler Scientific Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Semler Scientific Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.